|
End-of-day quote
2025-03-21
|
5-day change
|
1st Jan Change
|
|
6,040.00 KRW
|
-1.63%
|
 |
-.--%
|
-
|
|
24-12-29 |
Yeom Ju-hwan agreed to acquire 36.90% stake in mCureX Therapeutics, Inc. from PCL, Inc. for KRW 13.0 billion.
|
CI
| |
24-08-29 |
PCL, Inc. announced that it has received KRW 4.004999835 billion in funding
|
CI
| |
24-08-21 |
PCL, Inc. announced that it expects to receive KRW 4.004999835 billion in funding
|
CI
| |
24-06-24 |
PCL, Inc. announced that it has received KRW 9.99999838 billion in funding from JS & Partners Co., Ltd.
|
CI
| |
24-06-20 |
Tiger Company Ltd. announced that it has received KRW 8.3 billion in funding from PCL, Inc.
|
CI
| |
24-01-15 |
PCL, Inc. announced that it has received KRW 9.99999885 billion in funding from Global Emerging Markets
|
CI
| |
23-12-25 |
PCL, Inc. announced that it has received KRW 9.99999838 billion in funding from Global Emerging Markets
|
CI
| |
23-12-20 |
PCL, Inc. announced that it expects to receive KRW 9.99999885 billion in funding from Global Emerging Markets
|
CI
| |
23-12-14 |
PCL, Inc. announced that it expects to receive KRW 9.99999838 billion in funding from JS & Partners Co., Ltd.
|
CI
| |
23-05-31 |
PCL to Raise 36 Billion Won via Share Issuance
|
MT
| |
23-03-22 |
PCL, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
|
CI
| |
22-12-28 |
PCL, Inc. announced that it has received KRW 2.999990812 billion in funding from Hyeopsim Co ., Ltd.
|
CI
| |
22-12-21 |
PCL to Raise 3 Billion Won via Share Issuance; Shares Jump 4%
|
MT
| |
22-12-20 |
PCL, Inc. announced that it expects to receive KRW 2.999990812 billion in funding from Hyeopsim Co ., Ltd.
|
CI
| |
22-12-11 |
PCL, Inc. announced that it has received KRW 12.060247575 billion in funding
|
CI
| |
22-11-10 |
OliX Pharmaceuticals, Inc agreed to acquire 6.63% stake in PCL, Inc. for KRW8.04 billion.
|
CI
| |
22-04-07 |
PCL, Inc.(KOSDAQ:A241820) dropped from S&P Global BMI Index
|
CI
| |
21-09-20 |
PCL, Inc.(KOSDAQ:A241820) added to S&P Global BMI Index
|
CI
| |
21-06-22 |
MCureX Therapeutics, Inc. announced that it expects to receive KRW 2 billion in funding from OliX Pharmaceuticals,Inc, PCL, Inc., Samyang Holdings Corporation
|
CI
| |
21-03-24 |
PCL, Inc. announced that it has received KRW 40.499938368 billion in funding from a group of investors
|
CI
| |
21-03-23 |
Datametrex AI Limited Secures Authorization by Health Canada for PCL Inc.'s COVID19 Rapid Antigen Test Kit
|
CI
| |
21-03-17 |
PCL, Inc. announced that it expects to receive KRW 40.499938368 billion in funding from a group of investors
|
CI
| |
20-09-01 |
Datametrex AI Limited Announces Submission of a Medical Devices Interim Order Request Form to Approve PCL, Inc.’s COV05 COVID19 Rapid Antigen Detection Kits to Health Canada
|
CI
| |
20-08-12 |
Datametrex AI Limited Secures Rights to Sell and Distribute Pcl, Inc.’s COV05 COVID19 Rapid Antigen Detection Kits
|
CI
| |
19-10-30 |
PCL, Inc. announced that it has received KRW 9.999993558 billion in funding from Korea Investment Partners Co. Ltd.
|
CI
|
No results match your criteria Select your edition All financial news and data tailored to specific country editions | 
